BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15504295)

  • 1. [Hammerhead ribozyme against human telomerase catalytic subunit (hTERT) induced apoptosis of liver cancer cells].
    Song DP; Lin JS; Fu GL; Sun XM; Kong XJ; Li PY; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):616-9. PubMed ID: 15504295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a recombinant vector of a mutant human telomerase reverse transcriptase gene in human bladder cancer cell line T24, and its clinical significance.
    Fu WJ; Hong BF; Huang JJ; Xu B; Gao JP; Wang XX; Huang CF
    BJU Int; 2005 Oct; 96(6):890-4. PubMed ID: 16153224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
    Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
    Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction and screening of a ribozyme targeting telomerase RNA and effects of telomerase ribozyme on proliferation and apoptosis of CNE-2Z cells].
    Zhao YH; Chen XY; R Arrand J
    Ai Zheng; 2004 Jan; 23(1):50-5. PubMed ID: 14720374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of telomerase activity by ribozyme targeted to human telomerase transcriptase].
    Qu Y; Liu SQ; Peng WZ; Liu BL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):323-8. PubMed ID: 12019445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
    Lei LX; Chen ZD
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells].
    Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transcriptional targeting gene therapy of double suicide gene driven by hTERT promoter in hepatic carcinoma].
    Fan WZ; Yang JY; Chen W; Huang YH; Wang Y; Zhang YQ; Li JP
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(43):3080-5. PubMed ID: 22333065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell].
    Ma JP; Zhan WH; Wang JP; Peng JS; Gao JS; Yin QW
    Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(22):1372-6. PubMed ID: 15634407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
    Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors.
    Chen SM; Tao ZZ; Hua QQ; Liu D; Chi HM; Cai Q
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):200-5. PubMed ID: 16490880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antisense human telomerase reverse transcriptase inhibits leukemia cell proliferation in vitro].
    Sun LB; Li CR; Wen JM; Wang GB; Zhang M; Yang J; Li RX
    Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):521-4. PubMed ID: 15151822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effect of IGF1R siRNA on the growth of human liver cancer SMMC7721 cell xenograft in nude mice].
    Niu J; Qian HX; Li XN; Han ZG
    Ai Zheng; 2007 Jul; 26(7):703-8. PubMed ID: 17626744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attenuation of telomerase activity by hammerhead ribozyme targeting the 5'-end of hTERT mRNA].
    Qu Y; Liu S; Liu B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):389-92. PubMed ID: 12362313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A DNA vector-based RNAi technology to inhibit the activity of the telomerase of cell line HCCLM3].
    Lu XD; Qin WX; Pan DN; Li JJ; Wan DF; Wen CJ; Li CJ; Gu JR; Yang SL
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1381-5. PubMed ID: 15387948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
    Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
    Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T
    Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.